MedPath

Clinda soap effects on acne vulgaris

Phase 3
Conditions
Acne vulgaris.
Acne vulgaris
Registration Number
IRCT201009254808N1
Lead Sponsor
Kurdistan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

1 - mild to moderate acne 2 – Age range of the patient between 15 to 35 years 3 - written consent of the patients. Exclusion criteria: 1 - Pregnancy and lactation 2-presense of any chronic diseases - 3 receiving antibiotics during the last month before study 4 - use of acnegenic drugs, vit B 12, litum, carbamazepine and phenytoin.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of Acne lesion. Timepoint: Monthly. Method of measurement: Assessment of the severity and count of lesions by dermatologist.
Secondary Outcome Measures
NameTimeMethod
Side effects (including erythema , scaling , dry skin and burning sensation or praritms). Timepoint: every month. Method of measurement: Examination of the patients by dermatologists.
© Copyright 2025. All Rights Reserved by MedPath